Skip to main content
Equibles

UBS Group AG

Position in SPRO — Spero Therapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to SPRO Full portfolio

Position in SPRO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$308,692
+$301,651 QoQ
Shares Held
139,680
+4542.1% QoQ
Ownership
0.240%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 59 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. SPRO ranks #318 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in SPRO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $308,692 139,680
2026-03-31 $7,041 3,009
2025-12-31 $271,320 116,447
2025-09-30 $50,949 27,101
2025-06-30 $23,760 8,194
2025-03-31 $2,034 2,826
2024-12-31 $145 141
2024-09-30 $23,488 17,529
2024-06-30 $430 331
2024-03-31 $9,851 5,728
2023-12-31 $483 329
2023-09-30 $32,832 27,135
2023-06-30 $39,252 27,071
2023-03-31 $60,206 41,523
2022-12-31 $79,027 45,682
2022-09-30 $45,816 22,908
2022-06-30 $559 755
2022-03-31 $6,568 755
2021-12-31 $529,642 33,082
2021-09-30 $530,611 28,822
2021-06-30 $26,426 1,893
2021-03-31 $456,717 31,027
2020-12-31 $278,188 14,347
2020-09-30 $5,580 500
2020-06-30 $80,530 5,952
2020-03-31 $72,663 8,993